CAS RN: 107753-78-6

Zafirlukast

Product Availability

Choose a grade to view its available package options.

8 package records4 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260522 25mg / 50mg Confirm by inquiry Shanghai, Shandong Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250528 100mg Out of stock Inquiry
Batchno.20251219 1mg In stock Shanghai, Wuhan Inquiry
Batchno.20260228 250mg Out of stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260106 100mg Out of stock Inquiry
Batchno.20251111 20mg Out of stock Inquiry
Batchno.20260306 25mg In stock Inquiry
Batchno.20260210 50mg In stock Inquiry
  • Product code: ICTZ0029
  • Purity/Analytical Methods: >98.0%(HPLC)
GET A QUOTE

107753-78-6 / cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate

zafirlukast | Accolate | ICI-204219

Standard CAS: 107753-78-6 Multi CAS: Yes

Basic Information

CAS
107753-78-6
Multi CAS
Yes
Molecular Formula
C31H33N3O6S
Molecular Weight
575.700000
Exact Mass
575.209007
SMILES
CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
InChI
InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)
InChIKey
YEEZWCHGZNKEEK-UHFFFAOYSA-N
Synonyms
zafirlukast Accolate ICI-204219 ICI 204,219 ICI 204219

Physical Properties

Melting Point
139 °C
Physical Description
Solid
State
Solid

Computed Properties

Structural Parameters

Heavy atom count
41
Aromatic heavy atom count
21
Fraction Csp3
0.29
Rotatable bonds
8
H-bond acceptors
7
H-bond donors
2
Molar refractivity
156.91
TPSA
115.73

LogP / Solubility

WLOGP
5.7
MLOGP
5.06
XLogP3
5.5
Consensus LogP
5.42
Log S (ESOL)
-6.85
Class (ESOL)
Insoluble
Log S (Ali)
-8.39
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.09
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.19

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.56
Leadlikeness
No
Synthetic Accessibility
5

Safety & Transport

GHS Hazard Statements
H413 (92.9%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]
Precautionary Statement Codes
P273, and P501

Get In Touch

Contact Us